Partner, Patent Attorney


Robert handles patent work in our chemistry team. Dealing mainly with drafting and prosecuting and advising on global portfolio management and invention capture, he has particular experience in the pharmaceutical and industrial chemistry sectors. He is also a leading member of our designs team.

Areas of Expertise

  • Antibody-drug conjugates
  • Small-molecule pharmaceuticals
  • Polymorphic forms of drugs
  • Polymers


Robert works with a range of clients including British universities, charities, spin out companies, SMEs and multi-nationals.


Robert has a first class degree in chemistry from Oxford University which included study and research in quantum chemistry. He joined Mewburn Ellis in 1995, qualifying as a Chartered Patent Attorney and a European Patent Attorney in 1999. He joined the partnership in 2001. Robert has over 20 years of experience as a professional representative at the EUIPO (1999 to 2020).

Robert is a member Standing Advisory Committee before the EPO (SACEPO), and Vice-President of FICPI’s Work and Study Commission (CET) in which capacities he meets the European Commission, EPO, EUIPO, WIPO and other patent offices. He is also a member of the Designs and Copyright committee of CIPA and represents FICPI-UK on the Marks and Designs Forum (MDF). He regularly speaks at conferences on a variety of topics including design law, entitlement to priority and privilege.


Robert is recognised in IAM Patent 1000, Managing IP, Who’s Who Legal and The Legal 500. 

He is described as “a chemistry and materials maven, the depth of whose analysis never fails to amaze” , his “first-rate global portfolio management work has won him admirers on all continents.”  What makes him stand-out is “his technical expertise, the quality of his advice, and successful representation in European opposition proceedings.”

Robert “balances his penchant for pharmaceutical patents with a thriving designs practice” - IAM Patent 1000, 2020

'Key Lawyer' - The Legal 500, 2019 and 2021